Why This Long-Time Skeptic Finally Upgraded Novo Nordisk (NVO) to Buy
Novo Nordisk (NVO), the company behind popular diabetes and obesity treatments Ozempic and Wegovy, saw its stock rise on Thursday after ...
Hosted on MSN3mon
A next-gen Ozempic falls short in a drug trial — and Novo Nordisk stock plunges 20%
The logo of Danish pharmaceutical company Novo Nordisk is pictured at their headquarters ... saw their stocks rise 5% and 3%, respectively, on Friday.